Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced Soft Tissue Sarcoma”

163 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 163 results

Testing effectiveness (Phase 2)Study completedNCT01016015
What this trial is testing

Temsirolimus and Cixutumumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Soft Tissue Sarcoma or Bone Sarcoma

Who this might be right for
Metastatic OsteosarcomaRecurrent Adult Soft Tissue SarcomaRecurrent Osteosarcoma+2 more
National Cancer Institute (NCI) 178
Early research (Phase 1)Study completedNCT05858710
What this trial is testing

Study of DPPG2-TSL-DOX Combined With Hyperthermia in Soft Tissue Sarcoma

Who this might be right for
Sarcoma, Soft Tissue
Thermosome GmbH 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT05836571
What this trial is testing

Testing Ipilimumab and Nivolumab Combination With or Without Cabozantinib in People >= 18 Years Old With Advanced Soft Tissue Sarcoma

Who this might be right for
Locally Advanced Extraskeletal Myxoid ChondrosarcomaLocally Advanced LeiomyosarcomaLocally Advanced Liposarcoma+7 more
National Cancer Institute LAO 66
Testing effectiveness (Phase 2)Active Not RecruitingNCT03282344
What this trial is testing

NKTR-214 in Combination With Nivolumab in Patients With Metastatic and/or Locally Advanced Sarcoma

Who this might be right for
SARCOMA
Memorial Sloan Kettering Cancer Center 88
Testing effectiveness (Phase 2)Study completedNCT00204646
What this trial is testing

Neoadjuvant Adriamycin and Ifosfamide Plus High-Dose ICE in Patients With Soft Tissue Sarcoma (STS)

Who this might be right for
Sarcoma, Soft Tissue
University Hospital Tuebingen
Testing effectiveness (Phase 2)Study completedNCT00005066
What this trial is testing

O6-benzylguanine and Carmustine in Treating Patients With Recurrent, Metastatic, or Locally Advanced Soft Tissue Sarcoma

Who this might be right for
Sarcoma
University of Chicago 12
Testing effectiveness (Phase 2)Ended earlyNCT04171700
What this trial is testing

Evaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR Genes

Who this might be right for
Solid Tumor
pharmaand GmbH 83
Testing effectiveness (Phase 2)Study completedNCT02048722
What this trial is testing

Daily Oral Regorafenib for Chemotherapy-Refractory, Metastatic and Locally Advanced Angiosarcoma

Who this might be right for
Adult AngiosarcomaRecurrent Adult Soft Tissue SarcomaStage III Adult Soft Tissue Sarcoma+1 more
Northwestern University 31
Testing effectiveness (Phase 2)Ended earlyNCT01876043
What this trial is testing

Efficacy and Safety of Plitidepsin in Patients With Advanced Unresectable or Metastatic, Relapsed/Refractory, Dedifferentiated Liposarcoma (DLPS): an Exploratory Phase II Multicenter Trial

Who this might be right for
Adult Patients With Unresectable Locally Advanced or Metastatic, Relapsed/Refractory Dedifferentiated Liposarcoma
Institut Bergonié 24
Testing effectiveness (Phase 2)Looking for participantsNCT01042379
What this trial is testing

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

Who this might be right for
Breast NeoplasmsBreast CancerBreast Tumors+8 more
QuantumLeap Healthcare Collaborative 5,000
Testing effectiveness (Phase 2)Study completedNCT04118166
What this trial is testing

Ipilimumab + Nivolumab + Cryotherapy in Metastatic or Locally Advanced Soft Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma
Kristen Ganjoo 30
Testing effectiveness (Phase 2)Study completedNCT01979393
What this trial is testing

IRCI Gynae Sarcomas, High Grade Uterine Sarcoma

Who this might be right for
Uterine Sarcoma
European Organisation for Research and Treatment of Cancer - EORTC 58
Large-scale testing (Phase 3)Study completedNCT02049905
What this trial is testing

Phase 3 Study to Treat Patients With Soft Tissue Sarcomas

Who this might be right for
Metastatic, Locally Advanced or Unresectable Soft Tissue Sarcoma
ImmunityBio, Inc. 433
Testing effectiveness (Phase 2)UnknownNCT03816475
What this trial is testing

Hypofractionated Radiotherapy in Locally Advanced Myxoid Liposarcomas of Extremities or Trunk Wall (LIPO-MYX Trial)

Who this might be right for
Myxoid Liposarcoma
Maria Sklodowska-Curie National Research Institute of Oncology 35
Testing effectiveness (Phase 2)Study completedNCT01327612
What this trial is testing

Open Label Extension Study of Conatumumab and Ganitumab (AMG 479)

Who this might be right for
Advanced Solid TumorsCarcinoidColorectal Cancer+6 more
Amgen 12
Testing effectiveness (Phase 2)Study completedNCT04216953
What this trial is testing

MEK Inhibitor and a PDL1 Inhibitor Patients With Locally Advanced and/or Metastatic Soft Tissue Sarcoma

Who this might be right for
Sarcoma,Soft Tissue
Centre Leon Berard 229
Testing effectiveness (Phase 2)Active Not RecruitingNCT06660810
What this trial is testing

Neoadjuvant Intralesional Injection of Talimogene Laherparepvec

Who this might be right for
Soft Tissue SarcomaSarcoma,Soft Tissue
John Rieth 2
Testing effectiveness (Phase 2)Looking for participantsNCT04094610
What this trial is testing

Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

Who this might be right for
Locally Advanced Solid TumorsMetastatic Solid TumorsLymphoma+1 more
Turning Point Therapeutics, Inc. 75
Early research (Phase 1)Looking for participantsNCT06066138
What this trial is testing

Therapeutic Drug Monitoring-Based Atezolizumab Dosing

Who this might be right for
Locally Advanced Alveolar Soft Part SarcomaMetastatic Alveolar Soft Part SarcomaLocally Advanced Non Small Cell Lung Cancer+7 more
National Cancer Institute (NCI) 30
Not applicableLooking for participantsNCT05761054
What this trial is testing

Sarcoma Preoperative Radiation With Simultaneous INTegrated Boost (SPRINT)

Who this might be right for
Soft Tissue Sarcoma
Azienda Ospedaliero-Universitaria Careggi 33
Load More Results